Congress wants to get serious about fixing the Medicare formula for reimbursing physicians, an initiative that would affect healthcare rates and expenditures more broadly.
The most recent temporary fix for the Medicare sustainable growth rate (SGR) expires Jan. 1, 2013. Without any action, Medicare payments to physicians would drop almost 30%. Many doctors say they won't treat seniors if such a draconian cut goes into effect.
The SGR was established in 1997 to better control Medicare costs by mandating reductions in doctor fees under certain conditions. Congress, however, has repeatedly overridden the planned cuts with temporary SGR remedies, running up a $300 billion liability in the process.
New legislation proposed by Reps. Allyson Schwartz (D-Pa.) and Joe Heck (R-Nev.) would accomplish this by replacing the SGR with short-term adjustments in physician rates. Additional payment reforms would reimburse clinicians in the future based on efficiency, quality and patient outcomes. Those goals attract strong support, particularly from doctors who are eager to avoid continued threats of steep Medicare rate cuts, followed by short-term remedies. The American Academy of Family Physicians, the American College of Physicians and several specialty societies have lined up behind the bill, praising its shift toward new reimbursement models that align payment with value.
The controversial issue is how to cover the huge cost of replacing the current SGR policy. Schwartz and Heck propose to tap into an "overseas contingency operations" fund that contains savings from the military pull-out from Iraq and Afghanistan. Many Republicans oppose this strategy as a budget-balancing gimmick; intense pressure to cut federal government spending makes it doubly difficult to find a way to offset the SGR liability.
Additional solutions might come from the Senate, where Finance Committee Chairman Max Baucus (D-Mont.) has launched a series of roundtable discussions with an eye to developing bipartisan legislation that establishes an alternative reimbursement scheme for physicians. At the first forum last month, former Medicare directors agreed that the SGR should be dropped and replaced by a new system for reimbursing physicians, but did not specify how to pay for it.
EXPERTS WEIGH IN
Gail Wilensky, Medicare chief from 1990 to 1992, backed strategies that relate payments to the ability of physicians to provide quality care and to manage multiple services for treating chronic diseases. Her successor, Bruce Vladeck, proposed replacing the SGR with an alternative update formula similar to those implemented by Medicare for hospitals, home care agencies and others.
While it's "essential" to drop the SGR, according to Tom Scully, Medicare chief from 2001 to 2004, he wants to retain controls on spending through bundled payments for episodes of care and to ultimately shift all seniors to Medicare Advantage plans. Scully's successor at the Centers for Medicare and Medicaid Services (CMS), Mark McClellan, cited work by physician specialty groups to devise bundled payments for specific conditions and treatments, along with care coordination models for their clinical areas. The goal is for such payment reforms to lead to improvements in care as well as cost savings that can support increases in total physician compensation.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
CVS Caremark Makes Changes in Diabetes Coverage for 2025
Published: November 25th 2024 | Updated: November 25th 2024CVS Caremark has removed several diabetes drugs favor of newer products and generics, and is even favoring an insulin infusion system developed by a company that was cofounded by Alan Lotvin, a former executive at CVS Health.
Read More